GSTM1 and thalassemia: The distribution of genotypes was 24.6% Hb‐SS, 8.8% Hb‐SC, and 7.8% Hb‐Sbeta‐thalassemia; the remaining patients had multiple known genotypes (2.5%), other genotypes (3.1%), or unknown genotypes (53.4%).